Skinvisible (SKVI) Total Current Liabilities (2010 - 2026)
Skinvisible's (SKVI) quarterly Total Current Liabilities came in at $5.5 million in Q2 2026, up 22.35% year-over-year from $4.5 million in Q2 2025, and up 4.92% quarter-over-quarter from $5.3 million in Q1 2026.
Analysis
Skinvisible (SKVI) Total Current Liabilities (2010 - 2026) Analysis & Trends
Skinvisible has disclosed Total Current Liabilities across 17 years of filings, most recently posting $5.5 million for Q2 2026.
- In Q2 2026, Total Current Liabilities rose 22.35% year-over-year to $5.5 million; the TTM figure through Jun 2026 stood at $5.5 million (up 22.35% YoY), while the FY2025 annual figure was $5.0 million, up 37.2% from the prior year.
- Total Current Liabilities came in at $5.5 million for Q2 2026 at Skinvisible, up from $5.3 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $5.5 million in Q2 2026 to a low of $2.7 million in Q1 2023.
- Average Total Current Liabilities over 5 years is $4.0 million, with a median of $3.8 million recorded in 2024.
- Year-over-year, Total Current Liabilities declined 12.62% in 2023 and soared 50.18% in 2024.
- Over 5 years, Total Current Liabilities stood at $3.6 million in 2022, then retreated by 3.64% to $3.5 million in 2023, then advanced by 4.12% to $3.7 million in 2024, then soared by 37.2% to $5.0 million in 2025, then gained by 10.33% to $5.5 million in 2026.
- Per Business Quant data, the three most recent Total Current Liabilities figures were $5.5 million in Q2 2026, $5.3 million in Q1 2026, and $5.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 54.90 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 41.64 Bn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | 27.73 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | 31.75 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | 32.65 Bn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | 37.11 Bn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | 354.06 Mn |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 1.31 Bn |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn | 607.80 Mn |
| 10 | Skinvisible | 1.08 Mn | 1.08 Mn | 5,000.00 | 5.54 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.54 Mn |
| Mar 31, 2026 | 5.28 Mn |
| Dec 31, 2025 | 5.02 Mn |
| Sep 30, 2025 | 4.77 Mn |
| Jun 30, 2025 | 4.53 Mn |
| Mar 31, 2025 | 4.26 Mn |
| Dec 31, 2024 | 3.66 Mn |
| Sep 30, 2024 | 4.64 Mn |
| Jun 30, 2024 | 4.02 Mn |
| Mar 31, 2024 | 4.09 Mn |
| Dec 31, 2023 | 3.51 Mn |
| Sep 30, 2023 | 3.24 Mn |
| Jun 30, 2023 | 2.98 Mn |
| Mar 31, 2023 | 2.73 Mn |
| Dec 31, 2022 | 3.64 Mn |
| Sep 30, 2022 | 3.62 Mn |
| Jun 30, 2022 | 3.41 Mn |
| Mar 31, 2022 | 3.07 Mn |
| Dec 31, 2021 | 3.06 Mn |
| Sep 30, 2021 | 3.11 Mn |